Sumitovant Biopharma, Sumitomo Pharma, and Myovant Sciences

Sumitovant Biopharma to Acquire all Outstanding Shares of Myovant for $27 Per Share in Cash Combination Provides Expertise and Resources to Address Unmet...

Related Keywords

United States , China , Osaka , Japan , Tokyo , Switzerland , Sumitomo Pharma , Maya Frutiger , Hiroshi Nomura , Sumitovant Biopharma , Mark Guinan , David Marek , Uneek Mehra , Myrtle Potter , Sumitomo Mitsui Banking Corporation , Jp Morgan Securities , Committee Of Myovant , Sumitomo Pharma Co Ltd , York Stock Exchange , Sumitomo Pharma Group , Women Health , Myovant Sciences , Meagher Flom , Exchange Commission , Sullivan Cromwell , Myovant Sciences Inc , Corporate Communications , Goldman Sachs Co , New York Stock Exchange , Sumitovant Biopharma Ltd , Head Of Corporate Communications , Outstanding Shares , Provides Expertise , Address Unmet Patient Needs , Prostate Cancer , Unanimously Recommended , Special Committee , Independent Directors , Sumitomo Mitsui Banking , New York Stock , Goldman Sachs , Biopharma Ltd , Investor Relations , Nyse Myov , Nc ,